Literature DB >> 33812015

The role of transcription factor Nrf2 in the toxicity of perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA) in C57BL/6 mouse astrocytes.

Saif A Alharthy1, Diane Hardej2.   

Abstract

Perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA) are members of perfluoroalkyl substances (PFAS). This study aimed to determine the protective role of Nrf2 against the toxicity of these agents. Nrf2-/- and wild-type astrocytes were exposed to PFOS (75-600 μM) and PFOA (400-1000 μM) for 24 h. Lactate dehydrogenase (LDH) release was significantly higher in nrf2-/- than in the wild-type astrocytes. Exposure to 600 μM PFOS and 800 μM PFOA showed significant increases in reactive oxygen species, lipid peroxidation, and apoptosis in nrf2-/- astrocytes as compared to wild-type astrocytes. The GSH/GSSG ratio was significantly decreased in nrf2-/- astrocytes when compared to wild-type astrocytes. Additionally, PFOS and PFOS caused dramatic ultrastructural alterations to the mitochondria. BHT pretreatment in wild-type cells decreased ROS production with exposure to both agents. Results of the present study conclude that PFOS and PFOA are cytotoxic to astrocytes and that nrf2 -/- cells are more sensitive to toxicity by these agents.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Astrocyte; Nrf2; Oxidative stress; Perfluorooctane sulfonate; Perfluorooctanoic acid

Year:  2021        PMID: 33812015     DOI: 10.1016/j.etap.2021.103652

Source DB:  PubMed          Journal:  Environ Toxicol Pharmacol        ISSN: 1382-6689            Impact factor:   4.860


  1 in total

1.  Replacement per- and polyfluoroalkyl substances (PFAS) are potent modulators of lipogenic and drug metabolizing gene expression signatures in primary human hepatocytes.

Authors:  Emily Marques; Marisa Pfohl; Wei Wei; Giuseppe Tarantola; Lucie Ford; Ogochukwu Amaeze; Jessica Alesio; Sangwoo Ryu; Xuelian Jia; Hao Zhu; Geoffrey D Bothun; Angela Slitt
Journal:  Toxicol Appl Pharmacol       Date:  2022-03-23       Impact factor: 4.460

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.